The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: amlodipine besylate     Quarter: 2016Q3

Total Records: 303     Number of Pages: 16

DRUGNAME PT EventCount
AMLODIPINE BESYLATE (CAMBER) Blood triglycerides increased 1
AMLODIPINE BESYLATE (CAMBER) Product substitution issue 1
Amlodipine Besylate (Watson Laboratories) Acute kidney injury 1
Amlodipine Besylate (Watson Laboratories) Asthenia 1
Amlodipine Besylate (Watson Laboratories) Blood lactic acid increased 1
Amlodipine Besylate (Watson Laboratories) Cardiomegaly 1
Amlodipine Besylate (Watson Laboratories) Fatigue 1
Amlodipine Besylate (Watson Laboratories) Hypotension 1
Amlodipine Besylate (Watson Laboratories) Oedema 1
Amlodipine Besylate (Watson Laboratories) Overdose 1
Amlodipine Besylate (Watson Laboratories) Pulmonary oedema 1
Amlodipine Besylate (Watson Laboratories) Stomatitis 1
Amlodipine Besylate (Watson Laboratories) Thrombosis 1
Amlodipine Besylate (Watson Laboratories) Troponin I increased 1
Amlodipine Besylate + Valsartan Coeliac disease 1
AMLODIPINE BESYLATE 2.5 ML Activities of daily living impaired 1
AMLODIPINE BESYLATE 2.5 ML Adverse reaction 1
AMLODIPINE BESYLATE 2.5 ML Asthenia 1
AMLODIPINE BESYLATE 2.5 ML Blood pressure fluctuation 1
AMLODIPINE BESYLATE 2.5 ML Decreased activity 1

Total Records: 303     Number of Pages: 16